About: Management of infantile hemangiomas during the COVID pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of infantile hemangiomas during the COVID pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Management of infantile hemangiomas during the COVID pandemic
Creator	Baselga, Eulalia Anthony, \| Amy, \| Brandon, \| Frieden, Ilona Shah, D Adams, Denise Catherine, \| Chamlin, Sarah Deepti Gupta, \| Denise, \| Drolet, Beth Garzon, Maria Haggstrom, Anita Holland, Kristen Horii, A Kimberly, \| Lauren, Christine Mancini, J Mathes, Erin Mccuaig, C Megha, \| Metry, W Morel, D Newell, D Nopper, J Pope, Elena Powell, Julie Püttgen, Katherine Siegel, Dawn Sonal, \| Tollefson, M
Source	Medline; PMC
abstract	The COVID‐19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas (IH) can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long‐term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of IH via telemedicine. FDA/EMA‐approved monitoring guidelines, clinical practice guidelines, and relevant, up‐to‐date publications regarding initiation and monitoring of beta‐blocker therapy were used to inform the recommendations. Clinical decision‐making guidelines about when telehealth is an appropriate alternative to in‐office visits, including medication initiation, dosage changes, and ongoing evaluation, are included. The importance of communication with caregivers in the context of telemedicine is discussed, and online resources for both hemangioma education and propranolol therapy are provided.
has issue date	2020-05-16(xsd:dateTime)
bibo:doi	10.1111/pde.14196
bibo:pmid	32298480
has license	no-cc
sha1sum (hex)	8d7f574f947416fa07d99bc8817926e5725c297a
schema:url	https://doi.org/10.1111/pde.14196
resource representing a document's title	Management of infantile hemangiomas during the COVID pandemic
has PubMed Central identifier	PMC7262142
has PubMed identifier	32298480
schema:publication	Pediatr Dermatol
resource representing a document's body	covid:8d7f574f947416fa07d99bc8817926e5725c297a#body_text
is schema:about of	named entity 'clinical practice guidelines' named entity 'observation' named entity 'https' named entity 'infantile' named entity 'SIGNIFICANT' named entity 'NEED TREATMENT' named entity 'ARTICLE' named entity 'HEMANGIOMAS' named entity 'RISK STRATIFICATION' named entity 'GROUP' named entity 'OBSERVATION' named entity 'INVESTIGATOR' named entity 'CONTINUED' named entity 'PATIENT CARE' named entity 'MARKED' named entity 'HEMANGIOMA' named entity 'MANAGEMENT' named entity 'DERMATOL' named entity 'doi' named entity 'cite' named entity 'morbidity' named entity 'created' named entity 'hemangiomas' named entity 'Investigator Group' named entity 'COVID-19 pandemic' named entity 'doi' named entity 'Pediatric' named entity 'infants' named entity 'Beta-blocker' named entity 'comorbidities' named entity 'propranolol' named entity 'primary care providers' named entity 'Hemangioma' named entity 'medical complications' named entity 'EMA' named entity 'risks and benefits' named entity 'abdominal compartment syndrome' named entity 'congestive heart failure' named entity 'blood pressure' named entity 'practicing clinicians' named entity 'FDA' named entity 'critical role' named entity 'propranolol' named entity 'diarrhea' named entity 'curate' named entity 'adverse events' named entity 'clinical practice guidelines' named entity 'gestational age' named entity 'health care systems' named entity 'FDA'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software